Home / Buying organisations / Organisation
BUYING ORGANISATION

The Royal Marsden NHS Foundation Trust

Published procurement activity · 24 tenders

ORGANISATION DETAILS

The Royal Marsden NHS Foundation Trust

Buyer information published with procurement notices.

Published identifier
GB-PPON PXLT-9823-WVCY
Address
London, UKI33, SW3 6JJ, United Kingdom
First notice
6 May 2025
Latest notice
21 Sept 2026
Find a Tender
All tenders24£45mCombined published value
Open2£3.6mCombined published value
Closed1£500kCombined published value
Awarded21£41mCombined published value
Cancelled0—No published tender values
ISSUED TENDERS

24 tenders

All · 24Open · 2Closed · 1Awarded · 21Cancelled · 0

RMH - Radiopharmaceuticals Xiel

The Royal Marsden NHS Foundation Trust · UKI33

Provision of CT Radiopharmaceuticals -Nanotop, MAG3, Tektrotyd, Illuccix

Sources Find a TenderPublished 12 Mar 2026Reference 022166-2026
£2.4mContract value · excl. VAT£2.9m incl. VAT

RMH - ACE PCR reagent rental

The Royal Marsden NHS Foundation Trust · UKI33

Provision 2 x ELITe BeGenius ACE PCR analysers and bring testing in house

Sources Find a TenderPublished 23 Feb 2026Reference 016034-2026
£473.7kContract value · excl. VAT£568.4k incl. VAT

RMH Radiopharmaceuticals GE

The Royal Marsden NHS Foundation Trust · UKI33

Provision of Radiopharmaceuticals

Sources Find a TenderPublished 17 Feb 2026Reference 014137-2026
£120kProposed award value · excl. VAT£144k incl. VAT

PET-CT FDG tracers for Private patients

The Royal Marsden NHS Foundation Trust · UKI33

the supply of FDG tracers used for PET-CT's in privately funded patients and research.

Sources Find a TenderPublished 11 Feb 2026Reference 012619-2026
£2.5mProposed award value · excl. VAT£3m incl. VAT

RMH clonoSEQ® Assay

The Royal Marsden NHS Foundation Trust · UKI33

The procurement of a next-generation sequencing (NGS)–based test assay designed for the detection and monitoring of minimal residual disease (MRD) in patients with certain haematologic malignancies, such as multiple myeloma, acute lymphoblastic leukaemia (ALL), and chronic lymphocytic leukaemia (CLL). The required goods and serv

Sources Find a TenderPublished 30 Dec 2025Reference ocds-h6vhtk-05fb40-2025-12-30T11:11:50Z
£1.2mProposed award value · excl. VAT£1.4m incl. VAT

Lifts Authorising Engineer Services

The Royal Marsden NHS Foundation Trust · UKI33

Provision of independent Lifts Authorising Engineer services, including statutory compliance assurance, technical advice, inspection oversight, certification review, and support to ensure safe operation and compliance with relevant legislation and standards across the Trust’s estate.

Sources Find a TenderPublished 24 Dec 2025Reference ocds-h6vhtk-05fd31-2025-12-24T11:08:47ZSector 71315400 — Building-inspection services
£45.6kContract value

Contract for Netspot (Gallium Ga 68 Dotatate)

The Royal Marsden NHS Foundation Trust · UKI33

Contract for Netspot Kits required by the trust

Sources Find a TenderPublished 8 Dec 2025Reference ocds-h6vhtk-05f0eb-2025-12-08T16:45:00Z
£316.8kProposed award value · excl. VAT£380.2k incl. VAT

Microbiology Services

The Royal Marsden NHS Foundation Trust · UKI33

The Royal Marsden is currently exploring alternative operating models for its microbiology services and is undertaking a market engagement exercise to gather insights from providers. The exercise is designed to be a fact-finding and there is no formal evaluation. Providers are encouraged to propose individual solutions on their

Sources Find a TenderPublished 28 Nov 2025Reference ocds-h6vhtk-05eafc-2025-11-28T12:28:43ZSector 85111800 — Pathology services
£3.1mEstimated value

Supply of Truseq compatible Duplex Y adaptors

The Royal Marsden NHS Foundation Trust · UKI33

The Laboratory at RMH is currently using these DNA adaptors for high throughput sequencing experiments. These reagents are required to deliver a service. The adaptors have been validated for tests that RMH offers as part of the Molecular Diagnostic service and are incorporated into Standard Operating Procedures.

Sources Find a TenderPublished 7 Nov 2025Reference ocds-h6vhtk-055db5-2025-11-07T08:44:44Z
£674.4kContract value · excl. VAT£809.3k incl. VAT

RMH - CAR-T Treatment

The Royal Marsden NHS Foundation Trust · UKI33

CAR-T treatment called Obecel developed to treat relapsed or refractory B-cell precursor acute lymphoblastic leukaemia (r/r B-ALL) which has recently become available to patients. The decision which treatment is most suitable applicable to a specific age group is a clinical one that would be decided by a Multi-Disciplinary Team

Sources Find a TenderPublished 24 Oct 2025Reference ocds-h6vhtk-05d335-2025-10-24T11:22:31+01:00
£380kProposed award value · excl. VAT£380k incl. VAT

Organisation details and tender classifications reflect information published by the original procurement sources. Similar buyer names are grouped only where an official identifier or compatible name and postcode provide a safe link.